The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global healthcare cold chain logistics market was valued at US$ 16.5 Billion in 2021.
We expect the global healthcare cold chain logistics market to exhibit a CAGR of 3.4% during 2022-2027.
The rising demand for outsourcing operations in the pharmaceutical and biopharmaceutical sector for
drugs, vaccines, clinical trial materials, etc., is primarily driving the global healthcare cold chain logistics
The sudden outbreak of the COVID-19 pandemic has led to the increasing utilization of healthcare cold
chain logistics for storing and transporting various temperature-sensitive healthcare products and
vaccines across numerous countries.
Based on the product, the global healthcare cold chain logistics market has been segmented into clinical
trial materials, vaccines, and biopharmaceuticals. Currently, vaccines hold the majority of the total
Based on the segment, the global healthcare cold chain logistics market can be divided into
transportation, packaging, and instrumentation. Among these, packaging currently exhibits a clear
dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, and Rest of
the World, where Asia Pacific currently dominates the global market.
Some of the major players in the global healthcare cold chain logistics market include
AmerisourceBergen Corporation (World Courier), Deutsche Post DHL Group, FedEx Corporation Services,
Inc., United Parcel Service of America, Inc., Kuehne + Nagel International AG, Cavalier Logistics, Inc., DB
Schenker, LifeConEx, American Airlines Cargo, Continental Group, and Marken Ltd.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at